Mitesco, Inc. filed a Form 8-K on November 20, 2026, disclosing an amendment to its Articles of Incorporation that increases authorized common stock from 500,000,000 shares to 20,000,000,000 shares, following shareholder written consent obtained on November 18, 2026.
Key Highlights
- Authorized shares increased to 20 billion: The Board initially approved an increase to 1,000,000,000 shares on November 5, 2026, then modified that consent on November 18, 2026 to 20,000,000,000 shares, each with a par value of $0.001.
- Shareholder approval secured: Shareholders holding 50.95% of the company's voting stock, voting on an as-converted basis, approved the increase by written consent on November 18, 2026.
- Current shares outstanding: According to the filing, the company currently has approximately 66 million shares outstanding and around 26 million shares in the float.
- Reserve concentration: The filing states the company currently holds over 900 million shares, representing 91% of its previously authorized shares, in reserve for convertible debt and other commitments.
- No specific transaction planned: The filing states that "there is no transaction or event under consideration that management believes would utilize the new level of authorized shares."
- Ongoing discussions: The company disclosed it continues discussions with acquisition candidates and regarding restructuring of its Bridge notes and Series A Preferred shares.
Mitesco Amends Articles of Incorporation, Citing Reserve Requirements
Mitesco, Inc. reported under Item 5.03 of its Form 8-K that its Board of Directors approved, via unanimous written consent on November 5, 2026, an initial increase in authorized common stock from 500,000,000 to 1,000,000,000 shares at a par value of $0.001 per share. On November 18, 2026, the Board modified that consent to set the authorized common stock at 20,000,000,000 shares. The filing noted that Series X Preferred shareholders were recommended to approve the Authorized Stock Increase, and that shareholders holding 50.95% of the company's voting stock, on an as-converted basis, provided written consent on November 18, 2026.
The filing explained the rationale for the increase in terms of existing obligations. The company currently holds over 900 million shares, amounting to 91% of its previously authorized share count, in reserve to cover potential issuance underlying convertible debt and other commitments. With approximately 66 million shares outstanding and around 26 million shares in the float, the company disclosed that the reserve requirements effectively exhausted capacity under the prior authorization level.
The company stated under Item 8.01 that the change in authorized shares "was not related to any particular transaction or event," and that management does not believe any current transaction or event under consideration would utilize the new authorization level. The company said it will file an information statement as soon as practical to inform shareholders of the change, and that the Board "is taking all steps necessary to implement the change." The filing was signed by Mack Leath, Chairman and CEO. No exchange or trading symbol is listed under Section 12(b) of the Act in the filing's registered-securities table.
What Was Disclosed
Mitesco, Inc. disclosed an amendment to its Articles of Incorporation increasing authorized common stock to 20,000,000,000 shares at $0.001 par value, approved by the Board on November 18, 2026 and by written consent of holders of 50.95% of voting stock on the same date.




Please wait processing your request...